IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $468,343 | -32.2% | 66,526 | -7.7% | 0.21% | -45.8% |
| Q3 2022 | $691,000 | +39.3% | 72,104 | +60.4% | 0.40% | +32.1% |
| Q2 2022 | $496,000 | -45.3% | 44,962 | -17.4% | 0.30% | -48.1% |
| Q1 2022 | $906,000 | -28.8% | 54,401 | -18.4% | 0.58% | -43.1% |
| Q4 2021 | $1,272,000 | -8.4% | 66,639 | +18.4% | 1.01% | +10.3% |
| Q3 2021 | $1,388,000 | +64.3% | 56,276 | +73.4% | 0.92% | +53.3% |
| Q2 2021 | $845,000 | +47.0% | 32,458 | +78.7% | 0.60% | +40.3% |
| Q1 2021 | $575,000 | -39.3% | 18,163 | -11.1% | 0.43% | -29.4% |
| Q4 2020 | $948,000 | +71.1% | 20,423 | +21.4% | 0.60% | +49.8% |
| Q3 2020 | $554,000 | +30.4% | 16,824 | +8.7% | 0.40% | +14.8% |
| Q2 2020 | $425,000 | – | 15,481 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |